On the hypothesis that the distinctive immunological TME of the brain determines the response to the anti–PD-1 antibody, the amounts of TILs and PD-L1 expression on tumor cells in the brain TME were compared with those of primary lung cancer specimens (Fig. 2). The gene discussed is PDCD1; the disease is lung cancer.